πŸ‡ΊπŸ‡Έ FDA
Patent

US 8492428

Small-molecule botulinum toxin inhibitors

granted A61KA61K31/675A61P

Quick answer

US patent 8492428 (Small-molecule botulinum toxin inhibitors) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/675, A61P, A61P31/04